Evidence map›Paper›PMID 32454652›Full record

ArticleTurkish journal of pharmaceutical sciences2018

Development of Andrographolide-Carboxymethyl Chitosan Nanoparticles: Characterization,

Retno Sari, Aty Widyawaruyanti, Franciscus B Tedy Anindita, Sinta Kusuma Astuti, Dwi Setyawan

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Molecules (Basel, Switzerland) · 2022
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Retno SariAirlangga University, Faculty of Pharmacy, Department of Pharmaceutics, Surabaya, Indonesia.ORCID https://orcid.org/0000-0002-3391-1877
Aty WidyawaruyantiAirlangga University, Faculty of Pharmacy, Department of Pharmacognosy and Phytochemistry, Surabaya, Indonesia.ORCID https://orcid.org/0000-0003-4639-1599
Franciscus B Tedy AninditaAirlangga University, Faculty of Pharmacy, Department of Pharmaceutics, Surabaya, Indonesia.
Sinta Kusuma AstutiAirlangga University, Faculty of Pharmacy, Department of Pharmaceutics, Surabaya, Indonesia.
Dwi SetyawanAirlangga University, Faculty of Pharmacy, Department of Pharmaceutics, Surabaya, Indonesia.ORCID https://orcid.org/0000-0001-8009-6054
Airlangga University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe purpose of this study was to investigate the effect of andrographolide-carboxymethyl chitosan nanoparticles formation on the physical characteristics, MATERIALS AND

methodsNanoparticles were prepared by ionic gelation method-spray drying using CaCl

resultsThe results of DTA and XRD showed that nanoparticle systems had a lower melting point and lower crystallinity degree. The drug dissolved from the nanoparticles was increased up to 6.5 times and the

conclusionThe formation andrographolide-carboxymethyl chitosan nanoparticles affected the physical characte-ristics of andrographolide. The decrease crystallinity of andrographolide resulted in a lower melting point of andrographolide. Such changes provided a positive impact to the drug dissolution and then its activity.

Indexed as

Andrographolidecarboxymethyl chitosanin vitro releasein vivo antimalarialionic gelationspray drying

Identifiers

PMID32454652
PMCPMC7228006
OpenAlexW2807027186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.